Back to User profile » Dr Yanling Cheng
Paper published by Dr Yanling Cheng:
Original Research
LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment
Cheng Y, Tang R, Li X, Wang B, Cheng Y, Xiao S, Sun P, Yu W, Li C, Lin X, Zhu Y
Journal of Hepatocellular Carcinoma 2022, 9:203-220
Published Date: 22 March 2022